Skip to content

Pulsed Dye Laser Treatment of Onychomycosis

Pulsed Dye Laser Treatment of Onychomycosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01915355
Enrollment
11
Registered
2013-08-02
Start date
2013-07-31
Completion date
2015-07-31
Last updated
2016-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Onychomycosis

Keywords

onychomycosis, nail, fungus

Brief summary

The purpose of this research is to investigate the use of the Candela V-beam Pulsed Dye Laser for the treatment of onychomycosis, or nail fungus. Hypothesis: Complete nail clearance will occur in approximately half of patients after 3 laser treatments.

Detailed description

10 patients will participate nationally. The investigators hope to enroll all 10 patients at Jefferson. Involvement in the study will last about 8-12 weeks for the subject. The entire study will take about 12 months to complete.

Interventions

DEVICEPulsed Dye Laser for the treatment of nail fungus

The purpose of this research is to investigate the use of the Candela V-beam Pulsed Dye Laser for the treatment of onychomycosis, a common nail fungus.

Sponsors

Thomas Jefferson University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Ages 18-65 years old * Diagnosis of onychomycosis based on positive fungal culture for dermatophyte and positive PAS from toenail clipping

Exclusion criteria

* HIV/immunosuppression * Candidal toenail infection * Prior PO antifungal therapy within last 6 months * Personal history of psoriasis, lichen planus, or significant photosensitivity disorder * Any serious generalized medical condition

Design outcomes

Primary

MeasureTime frameDescription
Total Nail Clearanceapproximately 12 weeksAfter 3 laser treatments, the subject should experience clinical clearance.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026